The Only Instrument-Free,
Rapid PCR Test

Our rapid PCR tests provide accurate and reliable results for healthcare providers all across the United States. We are a medical diagnostics company with portable PCR testing technology that may be implemented in both clinical and mobile laboratory settings. In recent years, healthcare has dominated the public discourse, and as a medical diagnostics company, Visby Medical strives to make access to infectious disease testing as easy and as accessible as possible. the palm of your hand

Reduce patient anxiety with a PCR test you can run on-site, right at the point of care — now available for three critical sexual health targets, in addition to our COVID-19 product.

PCR Results in
Less Than 30 Minutes

In a world where speed and accuracy in disease testing has become increasingly important, the efficient protection of public health depends on the delivery of fast and reliable infectious disease testing to affected communities as quickly as possible. The Visby Medical portable, instrument-free PCR test delivers results in minutes, not days, making our PCR test kits a revolution in the molecular diagnostics industry. The following are five key benefits to using Visby PCR in your lab or clinic, right at the point of care.

True PCR results in under 30 minutes

Portable, deployable, and scalable

Accuracy of 97% or greater1

No instrument,
no maintenance

No capital investment, no service contracts

Medical Company
with a Human Focus

As a molecular diagnostics company with over a decade of experience developing accurate, rapid testing for various disease targets, we recognize that there is always an anxious patient waiting. For that reason, we create highly-accurate, easy-to-run, rapid PCR testing kits to help contain and control the spread of dangerous pathogens fast. Whether it’s on-site or pop-up testing, our aim is to continue developing testing devices that are reliably accurate. The current lack of rapid PCR testing available to inform a timely and accurate diagnosis for the patient demonstrates the inherent need for the Visby Medical diagnostic platform in the ever-evolving healthcare continuum.

PCR results to treat in one visit. That’s a first!

Visby Medical reduced a ~6-day central lab wait time down to under 30 minutes at the point-of-care. You can now talk with your patient about the result, during the visit. Patient loss-to-care may become a thing of the past. That’s a positive impact you’ll appreciate.

5 feet
<5 inches

The biggest improvements are often the smallest.

Visby Medical shrank the traditional sofa-sized PCR lab-instrument down to the palm of your hand. Now it’s portable, and easily deployable, in a ~3 by 4 inch device. Revolutionary.

Greater than ~97% accuracy.
A small miracle.

Capable of identifying multiple pathogens from the same sample, the miniaturized Visby Medical device delivers greater than ~97%1 accuracy just like central lab instruments, only ~1,000 times smaller. That’s huge.

1. Instructions for Use.

Surge capacity, without capital investment or maintenance.

Is it instrument-free or is it cartridge-free? It’s both, because it’s all-in-one, single-use, and disposable. Add more tests as your testing demand increases. Scale back as patient demand subsides. Order today and begin testing as soon as tomorrow.2

2. Depending on shipping.


To the agencies and entities that supported us, we are proud to deliver the next generation of PCR diagnostics.

At Visby Medical, we humbly believe our new diagnostic platform will become the gold standard among PCR point-of-care devices, by delivering accurate results in under 30 minutes to empower clinicians with data-driven results, while with their patient.

    February 2, 2021: Visby receives a $12.3 million award from BARDA to speed development of its rapid, single-use Flu-COVID PCR Test.

    Read more

    November 23, 2020: Visby Medical Sexual Health Click Test clinical study, sponsored by NIH/NIAID, is published in The Lancet: “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”

    Read more

    October 6, 2020: Visby receives $10 Million from the NIH as part of its Rapid Acceleration of Diagnostics (RADx) initiative.

    Read more

    August 5, 2020: Visby Medical selected as the ONLY winner of $19 Million in the Antimicrobial Resistance (AMR) Diagnostic Challenge (co-sponsored by BARDA and the NIH).

    Read more

Are you ready to bring the power of lab PCR to your point of care clinic?

How to Buy

Fast, accurate results

True PCR results in under 30 minutes. Goodbye empiric treatment - hello data-driven decisions. No more compromising between speed and accuracy.


Enzyme-linked DNA detection provides a boost in sensitivity and enables colorimetric detection.

17 patents and counting

A tiny device, yet exceptionally big on innovation.

Tiny footprint

At ~3 by 4 inches small, it’s easily deployable at the point of care. Imagine PCR results at your fingertips, ending the need to send samples away (now you can bill for on-site tests).


Simply drop in the sample, slide the port, push the buttons, and plug it in. That’s it. The Visby Medical platform is a breeze to use at the point of care and requires little to no training.

No capital investment, no maintenance contracts

Be untethered from both! Is it instrument-free or cartridge-free? It’s both because it is all-in-one. No expensive service or repair contracts.

Streamlined — no separate instrument or cartridge needed

Elegantly simple, yet highly sophisticated, single-use design. That’s a big positive impact for a tiny device

    I started Visby Medical to solve the problem that at any given moment, millions of people are waiting for a diagnosis—often waiting for days when it should be minutes. I set out to create a tiny diagnostic tool with the gold standard accuracy of PCR but, unlike big central lab instruments, could deliver results fast, in minutes, so the clinician can make a data-driven decision. I wanted to create a diagnostic tool which would be small and portable enough to work anywhere, with no separate instrumentation, and which would be simple enough to be used by anyone, anywhere, anytime.

    Adam de la Zerda, PhD

    Founder, CEO

    The beauty of the Visby Medical platform isn’t just the accuracy and size of the device, but also the speed which enables doctors to maximize their time with patients, during that key initial visit. So, rather than spending precious time guessing, Visby Medical enables clinicians to spend time having a real conversation with the patient, listening and making a real connection, with real impact on public health and clinicians too. As a professor at Stanford Medical school, this is the standard of care we all aspire to: the ability to treat the whole patient — not just the disease.

    Gary Schoolnik, MD

    Chief Medical Officer

    Visby is important to the world and to business, not only because it has achieved unbelievable advances in PCR testing and diagnostics in general, but also because it is a purpose-driven company — and that is the future. Visby is among the first in a new era of purpose-driven companies helping to ensure free enterprise builds a better world.

    Peter Löscher

    Former president, Global Human Health at global pharmaceutical company Merck & Co

    The COVID-19 pandemic has highlighted the vital importance of very accurate, quick-response, single-use tests. With them, lives can return to normal both in developed and developing countries without causing numerous casualties. Visby’s team has shown how brilliant entrepreneurship can bring groundbreaking innovation in testing, not just for COVID-19, but for all infectious diseases, now and in the future.

    Sir Ronald Cohen

    Preeminent international philanthropist, venture capitalist, private equity investor and social innovator

    Visby has solved one of the most important problems in testing. Now the most extraordinary diagnostic technology, PCR, is simple and accessible. This is an enormous advancement in putting healthcare in the hands of people.

    Dr. Rick Klausner

    Founder and Executive Chairman of Lyell Immunopharma, Inc., and president of the Milky Way Research Foundation

    PCR, when appropriately applied, generates a highly sensitive and precise result. Visby’s PCR technology is so sensitive that it will pick up a signal that is likely to otherwise be missed. They have miniaturized PCR, validating it in the most rigorous fashion that satisfies both the compliance agencies as well as practicing physicians. This is a very important patient-friendly advance, which will lead to a new class of point of care diagnostics.

    Dr. Shlomo Melmed

    Visby Medical Board Member, Executive Vice President of Academic Affairs, Dean of the Medical Faculty and Professor of Medicine at Cedars-Sinai

What is Visby PCR?

It’s a full 40-cycle PCR lab in an incredibly small package. It’s also fast, creating a whole new category at the intersection of accuracy, speed and deployability. That’s a powerful new force that delivers a new era in results-driven diagnosis and informed treatment, during the patient visit.

Visby Medical in the media


    Visby Medical's Adam de la Zerda on Bloomberg Quicktake.


    Visby Medical CEO on developing a portable PCR test for Coronavirus.


    Visby Medical CEO Adam de la Zerda discusses COVID-19 Test Production.


    Visby Medical's COVID-19 test gets FDA EUA.


    Yahoo! Finance

    Visby Medical to develop rapid flu-COVID PCR test as U.S. cases top 27M



    Visby Medical on AACC TV